US Stock MarketDetailed Quotes

GALT Galectin Therapeutics

Watchlist
  • 2.460
  • +0.020+0.82%
Close Sep 6 16:00 ET
  • 2.390
  • -0.070-2.85%
Post 20:01 ET
153.20MMarket Cap-3153P/E (TTM)

Galectin Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.25%-8.33M
-12.16%-12.11M
-6.15%-32.97M
35.05%-4.7M
8.51%-7.64M
-32.38%-9.83M
-34.21%-10.79M
-27.76%-31.06M
-4.14%-7.24M
-67.01%-8.35M
Net income from continuing operations
-35.74%-12.37M
0.33%-11.49M
-5.91%-41.07M
5.99%-10M
-21.30%-10.43M
5.19%-9.11M
-16.06%-11.53M
-27.02%-38.78M
-47.26%-10.63M
-0.92%-8.6M
Operating gains losses
77.96%-108K
12.87%868K
177.56%432K
-21.66%-337K
118.75%490K
-78.18%-490K
435.81%769K
-303.62%-557K
41.81%-277K
34.94%224K
Depreciation and amortization
156.25%9K
-71.88%9K
3.13%33K
12.50%9K
14.29%8K
-328.57%-16K
220.00%32K
-21.95%32K
-27.27%8K
-30.00%7K
Other non cash items
47.34%249K
44.44%208K
70.00%697K
43.28%192K
62.71%192K
116.67%169K
80.00%144K
44.88%410K
-18.79%134K
972.73%118K
Change In working capital
450.78%3.15M
-164.03%-2.31M
-5.84%4.68M
73.18%4.93M
294.23%1.52M
-151.97%-898K
-174.55%-873K
25.55%4.97M
3,491.67%2.85M
-128.39%-780K
-Change in prepaid assets
-21.45%216K
-20.77%145K
-189.11%-90K
-19.37%-801K
-20.44%253K
-6.46%275K
14.38%183K
55.38%101K
21.98%-671K
-5.92%318K
-Change in payables and accrued expense
350.13%2.93M
-132.01%-2.45M
-2.03%4.77M
62.93%5.74M
214.94%1.26M
-181.80%-1.17M
-204.45%-1.06M
25.05%4.87M
353.61%3.52M
-145.58%-1.1M
Cash from discontinued investing activities
Operating cash flow
15.25%-8.33M
-12.16%-12.11M
-6.15%-32.97M
35.05%-4.7M
8.51%-7.64M
-32.38%-9.83M
-34.21%-10.79M
-27.76%-31.06M
-4.14%-7.24M
-67.01%-8.35M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
----
----
--0
----
----
----
----
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
3.76%10.38M
0.00%10M
300.33%40.03M
0.00%10M
10.03M
10M
10M
-72.84%10M
0.01%10M
0
Net issuance payments of debt
0.00%10M
0.00%10M
200.00%30M
0.00%10M
--0
--10M
--10M
-66.67%10M
0.00%10M
--0
Proceeds from stock option exercised by employees
----
----
--10.03M
--0
----
----
----
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
3.76%10.38M
0.00%10M
300.33%40.03M
0.00%10M
--10.03M
--10M
--10M
-72.84%10M
0.01%10M
--0
Net cash flow
Beginning cash position
30.87%23.56M
38.02%25.66M
-53.11%18.59M
28.62%20.36M
-25.69%17.97M
-43.05%18M
-53.11%18.59M
46.08%39.65M
-56.75%15.83M
-23.48%24.18M
Current changes in cash
6,290.91%2.04M
-254.97%-2.11M
133.57%7.07M
91.89%5.3M
128.70%2.4M
99.56%-33K
92.63%-593K
-268.37%-21.06M
-9.42%2.76M
-266.87%-8.35M
End cash Position
42.48%25.6M
30.87%23.56M
38.02%25.66M
38.02%25.66M
28.62%20.36M
-25.69%17.97M
-43.05%18M
-53.11%18.59M
-53.11%18.59M
-56.75%15.83M
Free cash flow
15.25%-8.33M
-12.16%-12.11M
-6.15%-32.97M
35.05%-4.7M
8.51%-7.64M
-32.38%-9.83M
-34.21%-10.79M
-27.76%-31.06M
-4.14%-7.24M
-67.01%-8.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.25%-8.33M-12.16%-12.11M-6.15%-32.97M35.05%-4.7M8.51%-7.64M-32.38%-9.83M-34.21%-10.79M-27.76%-31.06M-4.14%-7.24M-67.01%-8.35M
Net income from continuing operations -35.74%-12.37M0.33%-11.49M-5.91%-41.07M5.99%-10M-21.30%-10.43M5.19%-9.11M-16.06%-11.53M-27.02%-38.78M-47.26%-10.63M-0.92%-8.6M
Operating gains losses 77.96%-108K12.87%868K177.56%432K-21.66%-337K118.75%490K-78.18%-490K435.81%769K-303.62%-557K41.81%-277K34.94%224K
Depreciation and amortization 156.25%9K-71.88%9K3.13%33K12.50%9K14.29%8K-328.57%-16K220.00%32K-21.95%32K-27.27%8K-30.00%7K
Other non cash items 47.34%249K44.44%208K70.00%697K43.28%192K62.71%192K116.67%169K80.00%144K44.88%410K-18.79%134K972.73%118K
Change In working capital 450.78%3.15M-164.03%-2.31M-5.84%4.68M73.18%4.93M294.23%1.52M-151.97%-898K-174.55%-873K25.55%4.97M3,491.67%2.85M-128.39%-780K
-Change in prepaid assets -21.45%216K-20.77%145K-189.11%-90K-19.37%-801K-20.44%253K-6.46%275K14.38%183K55.38%101K21.98%-671K-5.92%318K
-Change in payables and accrued expense 350.13%2.93M-132.01%-2.45M-2.03%4.77M62.93%5.74M214.94%1.26M-181.80%-1.17M-204.45%-1.06M25.05%4.87M353.61%3.52M-145.58%-1.1M
Cash from discontinued investing activities
Operating cash flow 15.25%-8.33M-12.16%-12.11M-6.15%-32.97M35.05%-4.7M8.51%-7.64M-32.38%-9.83M-34.21%-10.79M-27.76%-31.06M-4.14%-7.24M-67.01%-8.35M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow ----------0------------------0--------
Financing cash flow
Cash flow from continuing financing activities 3.76%10.38M0.00%10M300.33%40.03M0.00%10M10.03M10M10M-72.84%10M0.01%10M0
Net issuance payments of debt 0.00%10M0.00%10M200.00%30M0.00%10M--0--10M--10M-66.67%10M0.00%10M--0
Proceeds from stock option exercised by employees ----------10.03M--0--------------0--0----
Cash from discontinued financing activities
Financing cash flow 3.76%10.38M0.00%10M300.33%40.03M0.00%10M--10.03M--10M--10M-72.84%10M0.01%10M--0
Net cash flow
Beginning cash position 30.87%23.56M38.02%25.66M-53.11%18.59M28.62%20.36M-25.69%17.97M-43.05%18M-53.11%18.59M46.08%39.65M-56.75%15.83M-23.48%24.18M
Current changes in cash 6,290.91%2.04M-254.97%-2.11M133.57%7.07M91.89%5.3M128.70%2.4M99.56%-33K92.63%-593K-268.37%-21.06M-9.42%2.76M-266.87%-8.35M
End cash Position 42.48%25.6M30.87%23.56M38.02%25.66M38.02%25.66M28.62%20.36M-25.69%17.97M-43.05%18M-53.11%18.59M-53.11%18.59M-56.75%15.83M
Free cash flow 15.25%-8.33M-12.16%-12.11M-6.15%-32.97M35.05%-4.7M8.51%-7.64M-32.38%-9.83M-34.21%-10.79M-27.76%-31.06M-4.14%-7.24M-67.01%-8.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg